Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous corona...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael Megaly, Marwan Saad, Emmanouil S Brilakis
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/5fa0cc149b4b475c9d3140cdd71076aa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5fa0cc149b4b475c9d3140cdd71076aa
record_format	dspace
spelling	oai:doaj.org-article:5fa0cc149b4b475c9d3140cdd71076aa2021-12-04T16:01:10ZRole of Drug-coated Balloons in Small-vessel Coronary Artery Disease10.15420/usc.2019.4.11758-390X1758-3896https://doaj.org/article/5fa0cc149b4b475c9d3140cdd71076aa2019-01-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2019.4.1https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XPercutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.Michael MegalyMarwan SaadEmmanouil S BrilakisRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 13, Iss 1, Pp 16-20 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Michael Megaly Marwan Saad Emmanouil S Brilakis Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
description	Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.
format	article
author	Michael Megaly Marwan Saad Emmanouil S Brilakis
author_facet	Michael Megaly Marwan Saad Emmanouil S Brilakis
author_sort	Michael Megaly
title	Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_short	Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_full	Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_fullStr	Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_full_unstemmed	Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_sort	role of drug-coated balloons in small-vessel coronary artery disease
publisher	Radcliffe Medical Media
publishDate	2019
url	https://doaj.org/article/5fa0cc149b4b475c9d3140cdd71076aa
work_keys_str_mv	AT michaelmegaly roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease AT marwansaad roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease AT emmanouilsbrilakis roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease
_version_	1718372796808036352

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Ejemplares similares